WO1995032297A1 - Novel chromosome fragment and its use as a vector - Google Patents
Novel chromosome fragment and its use as a vector Download PDFInfo
- Publication number
- WO1995032297A1 WO1995032297A1 PCT/GB1995/001195 GB9501195W WO9532297A1 WO 1995032297 A1 WO1995032297 A1 WO 1995032297A1 GB 9501195 W GB9501195 W GB 9501195W WO 9532297 A1 WO9532297 A1 WO 9532297A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chromosome
- vector
- dna
- cells
- fragment
- Prior art date
Links
- 210000000349 chromosome Anatomy 0.000 title claims abstract description 112
- 239000012634 fragment Substances 0.000 title claims abstract description 70
- 239000013598 vector Substances 0.000 title claims abstract description 57
- 238000000034 method Methods 0.000 claims abstract description 36
- 210000001182 human Y chromosome Anatomy 0.000 claims abstract description 30
- 210000002230 centromere Anatomy 0.000 claims abstract description 20
- 238000001502 gel electrophoresis Methods 0.000 claims abstract description 17
- 230000022131 cell cycle Effects 0.000 claims abstract description 12
- 238000005204 segregation Methods 0.000 claims abstract description 9
- 230000010076 replication Effects 0.000 claims abstract description 7
- 241001465754 Metazoa Species 0.000 claims abstract description 6
- 238000001415 gene therapy Methods 0.000 claims abstract description 6
- 210000004027 cell Anatomy 0.000 claims description 108
- 108020004414 DNA Proteins 0.000 claims description 84
- 238000009396 hybridization Methods 0.000 claims description 38
- 108090000623 proteins and genes Proteins 0.000 claims description 30
- 238000002474 experimental method Methods 0.000 claims description 19
- 108091035539 telomere Proteins 0.000 claims description 19
- 210000003411 telomere Anatomy 0.000 claims description 19
- 102000055501 telomere Human genes 0.000 claims description 19
- 230000000717 retained effect Effects 0.000 claims description 16
- 230000002062 proliferating effect Effects 0.000 claims description 8
- 239000003550 marker Substances 0.000 claims description 7
- 230000011278 mitosis Effects 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 239000013611 chromosomal DNA Substances 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 210000004507 artificial chromosome Anatomy 0.000 abstract description 4
- 238000013467 fragmentation Methods 0.000 abstract description 3
- 238000006062 fragmentation reaction Methods 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 2
- 210000002593 Y chromosome Anatomy 0.000 description 29
- 239000000523 sample Substances 0.000 description 28
- 238000004458 analytical method Methods 0.000 description 17
- 239000002953 phosphate buffered saline Substances 0.000 description 13
- 239000013612 plasmid Substances 0.000 description 13
- 230000008685 targeting Effects 0.000 description 12
- 108091060290 Chromatid Proteins 0.000 description 8
- 210000004756 chromatid Anatomy 0.000 description 8
- 239000003298 DNA probe Substances 0.000 description 7
- 238000013507 mapping Methods 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
- 230000032823 cell division Effects 0.000 description 6
- 238000012217 deletion Methods 0.000 description 6
- 230000037430 deletion Effects 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 230000010354 integration Effects 0.000 description 6
- 241000699800 Cricetinae Species 0.000 description 5
- 108020003215 DNA Probes Proteins 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
- 108020004487 Satellite DNA Proteins 0.000 description 5
- 230000031016 anaphase Effects 0.000 description 5
- 230000031864 metaphase Effects 0.000 description 5
- 230000000394 mitotic effect Effects 0.000 description 5
- 229940081969 saccharomyces cerevisiae Drugs 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000002509 fluorescent in situ hybridization Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 238000002744 homologous recombination Methods 0.000 description 4
- 230000006801 homologous recombination Effects 0.000 description 4
- 210000004754 hybrid cell Anatomy 0.000 description 4
- 230000008707 rearrangement Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- 101150096273 ADE2 gene Proteins 0.000 description 3
- 208000037088 Chromosome Breakage Diseases 0.000 description 3
- 101100059658 Mus musculus Cetn4 gene Proteins 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 102000018120 Recombinases Human genes 0.000 description 3
- 108010091086 Recombinases Proteins 0.000 description 3
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000005886 chromosome breakage Effects 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000001638 lipofection Methods 0.000 description 3
- 210000000723 mammalian artificial chromosome Anatomy 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 3
- 230000016853 telophase Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- BRZYSWJRSDMWLG-DJWUNRQOSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-DJWUNRQOSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 241000699802 Cricetulus griseus Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 108010052160 Site-specific recombinase Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000035199 Tetraploidy Diseases 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 101150050575 URA3 gene Proteins 0.000 description 2
- 210000001766 X chromosome Anatomy 0.000 description 2
- 108010027570 Xanthine phosphoribosyltransferase Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000024321 chromosome segregation Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000002743 insertional mutagenesis Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 210000000415 mammalian chromosome Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000007479 molecular analysis Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- -1 oxYl Chemical class 0.000 description 2
- 210000000745 plant chromosome Anatomy 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000012679 serum free medium Substances 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
- QLHLYJHNOCILIT-UHFFFAOYSA-N 4-o-(2,5-dioxopyrrolidin-1-yl) 1-o-[2-[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutanoyl]oxyethyl] butanedioate Chemical compound O=C1CCC(=O)N1OC(=O)CCC(=O)OCCOC(=O)CCC(=O)ON1C(=O)CCC1=O QLHLYJHNOCILIT-UHFFFAOYSA-N 0.000 description 1
- 101710141722 Arylsulfatase Proteins 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 208000037051 Chromosomal Instability Diseases 0.000 description 1
- NNJPGOLRFBJNIW-UHFFFAOYSA-N Demecolcine Natural products C1=C(OC)C(=O)C=C2C(NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 108010054218 Factor VIII Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 241000220010 Rhode Species 0.000 description 1
- 101001025539 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Homothallic switching endonuclease Proteins 0.000 description 1
- 235000013290 Sagittaria latifolia Nutrition 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 239000008049 TAE buffer Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
- 229960003896 aminopterin Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000012832 cell culture technique Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 235000015246 common arrowhead Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000037230 mobility Effects 0.000 description 1
- 238000003322 phosphorimaging Methods 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Definitions
- Novel chromosome fragment and Its use as a vector
- the present invention relates to the field of molecular genetics and in particular to artificial chromosomes, to their preparation in particular using telomere-directed chromosome fragmentation techniques and to their use as DNA vectors, for instance for application in gene therapy and animal transgenesis.
- yeast artificial chromosomes Following work with yeast artificial chromosomes (YACs) , there is currently widespread interest in the prospect of building artificial chromosome vectors from other hosts such as mammals and plants, for gene therapy and animal transgenesis.
- MACs mammalian artificial chromosomes
- satellite DNA composed of tandemly repeating sequences, is found at or close to the centromeres of many multicellular eukaryotes but has often been dismissed as being without functional significance because it is polymorphic and evolves rapidly.
- human alphoid satellite DNA Manuelidis, 1978
- Alphoid DNA has been introduced into either monkey (Haaf et al., 1992) or hamster chromosomes (Heartlein and Latt, 1988) and appeared to cause the chromosomes to behave as though they were dicentric: they lagged at anaphase and were structurally unstable.
- Insertional mutagenesis using existing vector systems poses problems, particularly where megabase sized fragments of DNA are to be introduced in a defined sequence environment into the genomes of humans and animals.
- the present invention provides a vector comprising a chromosome fragment wliich fragment comprises sequences 5 which have centromeric activity, is capable of replication and segregation during cell cycle, and is of such a size that it can be resolved using gel electrophoresis .
- the present invention also provides a method for obtaining a chromosome fragment for use as a vector as described above which method comprises dissecting a chromosome in such a manner that a fragment retaining centromere function is retained.
- a preferred method of the present invention comprises using cloned telomeric DNA to dissect a chromosome fragment containing the centromere.
- this employs a pair of vectors each containing telomeric DNA, a marker gene, and chromosomal DNA from the centromeric region in opposite orientations in the two vectors, introducing the vectors into cells containing the chromosome, selecting cells which have stably integrated vector, and isolating a clone containing a chromosome derivative which has lost one arm of the chromosome but retained the other arm truncated by telomere-directed breakage within the centromeric array, such clone segregating accurately at mitosis and being retained by cells proliferating in the absence of selection.
- the selected clone is then subjected to a further round of telomere-directed breakage to obtain a mini-chromosome fragment which is maintained stably by cells proliferating in culture.
- the second round breakage construct will suitably comprise telomeric DNA and a marker gene under the control of appropriate control agents such as promoters.
- An example of a suitable second round breakage construct is a linearised plasmid containing a 1.2kb stretch of human telomeric DNA, an
- the applicants' have identified a number of useful chromosome fragments which are derived from the human Y chromosome.
- the fragments are derived either from the short arm of the chromosome or the long arm of the human Y chromosome.
- Preferred small fragments have been isolated from the long arm of the human Y chromosome.
- the present invention provides a vector comprising a linear derivative of the human Y chromosome which includes at least some alphoid DNA, said fragment being capable of replication and segregation during cell cycle, and capable of resolution by gel electrophoresis.
- a fragment derived solely from the short arm of the human Y chromosome is approximately 8Mb in size.
- This fragment is suitably prepared by effecting the steps of carrying out a first telomere-directed truncation of the human Y chromosome, isolating stably segregating a fragment which contains only short arm and alphoid DNA, carrying out a second telomere-directed truncation of the isolated fragment, and isolating a shorter stably segregating fragment.
- a cell line containing this fragment designated ⁇ l was deposited at the European
- Fragments derived using a similar telomere directed truncation technique have been obtained from the long arm of the human Y chromosome. Fragments of approximately 6Mb in size and also as small as 3.5Mb in size are obtained in this way. The structure of these fragments has not been fully elucidated and it is believed that some form of rearrangement, possibly involving movement of the centomere takes place. However the fragments so obtained are capable of replication and segregation and their size makes them very useful as vectors.
- Cell lines containing three such fragments designated ⁇ 7, ⁇ 128 and ⁇ 196 were deposited at the ECACC on 23 May 1995 under the accession numbers 95052343, 95052344 and 95052345 respectively. ⁇ 7 and ⁇ 128 were found to be similar but not identical in size and are approximately 6Mb long. ⁇ 196 was found to be approximately 9Mb long.
- the invention comprises a vector as described above into which a gene encoding a desired protein has been incorporated. Furthermore the invention provides a cell transformed using a vector as described above.
- the invention provides a method of carrying out gene therapy which comprises forming a vector as described above including a desired gene and incorporating the said vector into the host cells.
- the problems of insertional mutagenesis can be overcome.
- they will allow long tracts of DNA, potentially including multiple genes into hosts, suitably mammals or cells in tissue culture.
- Such vectors, being accurately reproduced during many generations, are extremely advantageous.
- the expression capable of 'replication and segregation during cell cycle' means that the DNA is accurately replicated and segregated for at least 100 and suitably at least 500 cell divisions and that preferably the chromosome is lost no more than once every 200 cell divisions suitably no more than once every 1000 cell divisions.
- fragments when a fragment is said to be resolved by gel electrophoresis, it is generally expected that this will have a size of no more than about 10Mb.
- fragments of this size or less preferably 6.0Mb or less and more preferably 3.5Mb or less, are used as the basis of DNA vectors.
- Figure 1 shows the design of initial targeting experiment to dissect the centromere region of the human Y chromosome with telomeres
- FIG. 1 illustrates the progress of the experiment of Figure 1
- FIG. 3 shows the results of an analysis of two cell lines obtained in the experiment by fluorescent in si tu hybridisation,*
- FIGS 4a-4c show the results of molecular studies carried out on the cell lines of Figure 3;
- Figures 5a-5b show the mapping of the EcoRI and Xbal sites flanking the constructs in the cell lines
- Figures 6a-6c show the results of fluorescent in situ hybridisation experiments looking at the mitotic behaviour of the Y chromosome and the derivatives;
- Figure 7 demonstrates the stable inheritance of one of the cell line and of a deleted derivative of the second
- Figure 8 illustrates the kinetics of variant accumulation in a culture of dividing cells
- Figure 9a and 9b illustrate the design of an experiment to further dissect one of the derivatives and the structure of the plasmid used in this experiment respectively;
- Figure 10 illustrates the progress of the second step of the experiment of Figure 9a;
- Figure 11 shows a map summary of the desired ⁇ l fragment;
- Figure 12 illustrates the stability of the final fragment obtained.
- Figure 13 shows fluorescent in situ hybridization of chromosomes isolated from the cell line containing ⁇ l.
- Figure 14 shows pulsed field gel analysis of DNA extracted from the cell line containing ⁇ l and from Schizosaccharomyces pombe.
- ⁇ Yq74 Y chromosome derivative
- telomeres Cells containing ⁇ Yq74 were taken and ⁇ Yq74 broken in a second round of telomere directed breakage. A novel fragment or mini-chromosome designated ⁇ l was produced. This was found to be a linear mini-chromosome of about 8Mb in size which could be separated using gel electrophoresis. It is maintained stably by cells proliferating in culture and contains selectable marker genes close to each of the two telomeres.
- DMEM Dulbecco's modified Eagle's medium
- Electroporation was also as described (Barnett et al. , 1993) .
- the protocol for colony hybridization was that of Avraham et al. (1989) except that Hybond nylon membranes were used. Clones to be identified by colony hybridization were originally plated out at about 200 colonies per 9 cm. plate and were subsequently purified by three further rounds of colony hybridization and cloning.
- microcell fusion protocol of Fournier (1981) was used except that microcells were separated from donor cells by centrifugation of colcemid treated donor cells for 70 minutes at 35,000g in a 1:1 mixture of Percoll (Pharmacia) and DMEM with 10% Foetal Calf Serum which contained Cytochalsin B at lO ⁇ g./ml. Two microcell containing bands formed and were aspirated from the gradient and the microcells, were harvested by centrifugation at l,000g for 15 minutes and then filtered successively through 8/ ⁇ m and 5 ⁇ m polycarbonate filters.
- Recipient cells were washed twice in phosphate buffered saline, incubated with the microcells for 15 minutes at 37°C in PBS containing Phytohaemagglutinin at lO ⁇ g/ml. The supernatant was then gently removed and the cells, coated with the microcells, were incubated in 50% polyethylene glycol 1500 in serum free DMEM for two minutes at 37°C. The cells were washed twice with serum free medium and then incubated for 10-15 minutes at 37°C in serum free medium. The cells were then incubated overnight in DMEM containing FCS, split and selection was applied.
- G418 was used to select for either HT1080 or 853 derivative cells carrying the G418 resistance gene.
- Fig 1 the 853 monochromosomal somatic cell hybrid line (Burk et al., 1985) was used as the source of the human Y chromosome. These cells proliferate quickly in culture and the absence of other human chromosomes in the hybrid make it easy to detect Y chromosome derivatives in a clone of cells .
- the orientation of the array is known (Cooper et al, 1993) and is indicated by the positions of the EcoRI and Xbal sites which occur once and twice respectively in each 5.7kb unit.
- Two targeting plasmids (A and B in Fig. 1) were constructed each containing a 5.7kb EcoRI fragment of Y chromosome DNA cloned from the alphoid array (Tyler-Smith and Brown (1987) , a gene encoding resistance to the antibiotic G418, a 1.2kb stretch of cloned telomeric DNA (Barnett et al., 1993) and a cassette to allow recovery of flanking sequences in S. cerevisiae.
- the G418 resistance gene used in the constructs was 2.2kb Accl-BamHI fragment of pSV 2 neo (Mulligan and Berg, 1980) .
- the fragment used in the targeting constructs to allow shuttling into S. cerevisiae was constructed from the URA3 containing Sal-lXhol fragment of pYAC4 (Burke et al., 1987) the CEN4 containing HpalClal fragment of pYAC4 and an ARS sequence contained in a 500bp Sstll-Hindlll fragment of the HO endonuclease gene (Kearsey, 1983) .
- telomeric sequences were contained in the 1.2kb Taql fragment described in Barnett et al. (1993) .
- the alphoid DNA in the appropriately linearized plasmid was intended to target it to the alphoid array and the telomeric DNA acts to cause chromosome breakage.
- the two plasmids differ in the respective orientations of the 5.7kb alphoid units and thus targeted breakage of the Y chromosome by these plasmids was expected to generate derivative chromosomes of reciprocal structures.
- the 853 cells were transfected with either of the linearized targeting plasmids A or B and screened in three successive ways for clones which contained Y chromosomes broken within the alphoid DNA. Firstly colony hybridization with Y long arm (DYZ1) and Y short arm (DXYS20) specific probes was used to identify clones which have deleted either all or part of either the long or short arms of the chromosome. Secondly gel electrophoresis and filter hybridization was used to other Y chromosome probes to map the extent of the deletions. Filter hybridization and gel electrophoresis were carried out as described in Barnett et al. , (1993) .
- the remaining clones which hybridized differentially to DXYS20 and DYZl contained Y chromosome fragments that had either integrated into or translocated onto hamster chromosomes.
- Probes used in the analysis of the Y chromosomes were as follows; 29cl for the telomere of Yp (Cooke et al. , 1986) , 62RI (Brown, 1988), ZFY (Page et al. , 1987), 115i (DXYS8) and pl6(DXYS6), (Geldwerth et al. , 1986) the 4.5kb Hindlll fragment of Y190 (DYZ5; Tyler-Smith et al. , 1988) pDP34 (DXYS1) (Page et al. , 1984) 50f2, 52d and 64a, (Guellan et al.
- a Y chromosome alphoid DNA probe identified a single locus of hybridization on a chromosome identical in size and appearance to the one identified by the human genomic DNA probe.
- the alphoid signal was at primary constriction of the Y chromosome and at or close to the end of ⁇ Yq74 or ⁇ Ypl34.
- Fig 4a The alphoid DNA was truncated and on the same restriction fragment as the targeting construct in ⁇ Yq74 and ⁇ Ypl34.
- DNA extracted from either 853 cells or from cells containing ⁇ Yq74 or ⁇ Ypl34 was restricted with the indicated enzyme, the digests were analysed by pulsed field gel electrophoresis and filter hybridization with a neo probe specific for the targeting construct and then with a Y alphoid probe. Markers are oligomers of ⁇ cI857 DNA.
- Fig 4b The targeting constructs have seeded new telomeres in ⁇ Yq74 and ⁇ Ypl34. DNA extracted from either 1 ⁇ .
- ⁇ Yq74 or ⁇ Ypl34 was digested in solution with Bal31 for progressively increasing lengths of time and then with Hindlll. Digests were analysed by gel electrophoresis and filter hybridization with a probe specific for the S. cerevisiae CEN4 sequence in each construct.
- Fig 4c The long range organization of the alphoid DNA in ⁇ Yq74 and ⁇ Ypl34.
- the restriction site mapping illustrated in A was extended and sites for the indicated enzymes placed in the DNA flanking the alphoid DNA in the original Y, ⁇ Yq74 and ⁇ Ypl3 to produce the map.
- DNA from the 853 and ⁇ Yq74 and ⁇ Ypl34 cell lines was restricted with six enzymes that do not cut within the alphoid DNA array and analyzed by filter hybridization after gel electrophoresis (Fig 4a) as described by Barnett et al., (1993) .
- Each chromosome contained a single alphoid DNA fragment which was smaller in ⁇ Yq74 and ⁇ Ypl34 than in the original cell line.
- the Bglll fragment derived from the 853 line was 550kb long and the fragments derived from the ⁇ Yq74 and.
- ⁇ Ypl34 lines were 145kb and 480kb long respectively.
- the alphoid fragments in the derived lines hybridized to a probe specific for the breakage construct demonstrating that the breakage constructs had integrated into the alphoid DNA (Fig 4a) .
- the telomeric location of the targeting constructs in ⁇ Yq74 and ⁇ Ypl34 was confirmed by demonstrating their sensitivity to Bal31 exonuclease digestion (Fig 4b) .
- the restriction site mapping experiments initiated in Fig 4a were extended and positioned the sites for other enzymes in the DNA flanking the alphoid arrays . Restriction site mapping confirmed that the constructs were intact. These maps were combined to produce a map (Fig. 4c) of the DNA flanking array in the original chromosome.
- the map was identical to the one generated in previous work (Tyler- Smith, 1987) using double digests and thus these results combine with the deletion analysis to indicate that the truncations have not been accompanied by other rearrangements.
- the restriction site mapping also established that ⁇ Yq74 and ⁇ Ypl34 hold 70kb of DNA of their respective alphoid arrays in common.
- Each 5.7kb alphoid unit contains a single EcoRI site and a pair of Xbal sites. These positions of these sites are known and they can be used to orient individual units .
- the EcoRI and Xbal sites flanking the constructs in ⁇ Yq74 and ⁇ Ypl34 were mapped.
- DNA from either ⁇ Yq74 or ⁇ Ypl34 was digested to completion with Bglll, partially restricted with either EcoRI or Xbal and analysed by gel electrophoresis and filter hybridization with a neo probe, illustrated in Figure 5a.
- Fig. 5b Restriction site maps deduced from Fig. 5a are shown in Fig. 5b. There are a number of unresolved bands at about 23kb in the second track of ⁇ Yq74 in A. The number of Xbal sites represented in the unresolved cluster is either three or four and has been arbritarily indicated as four. The alphoid arrays in the top and bottom panels are not aligned.
- Fluorescent in si tu hybridization to whole anaphase cells was used to examine the mitotic behaviour of the Y chromosome and the truncated derivatives.
- the techniques used was modified from the protocol developed by Funabiki et al. (1993) .
- the cells were grown for 36-48 hours after plating onto 22mm square coverslips, rinsed in PBS and then simultaneously fixed and permeabilised by a 30min. incubation in 20mM potassium phosphate, 130mM
- RNAase A in PBS at 37°C for one hour and then rinsed again in PBS.
- the DNA was denatured by a four minute incubation in 0.2M NaOH at room temperature and the coverslips were flooded with PBS.
- the coverslips were then plunged into ice cold PBS and then hybridized in si tu with biotinylated probe as described by Buckle and Rack (1993) and finally washed in SSC at 37°C. Detection was as described by Buckle and Rack (1993) and images were collected on a MRC 600 confocal microscope and transferred to a Titan 3000 workstation for manipulation and display. 3D projections were calculated and displayed using the software described by Highett and colleagues (1993) .
- Fig 6a shows anaphase segregation of the intact Y chromosome in the 853 cell line
- Fig 6b shows segregation of ⁇ Yq74
- Fig 6c shows what we saw most often with ⁇ Ypl34.
- ⁇ Ypl34 specifically lagged with respect to the other chromosomes and a particularly extreme example is seen in Fig 6d (a telophase cell) .
- the relative stability of the chromosomes in mitotically proliferating cells was determined by growing cells in the absence of applied selection and measuring the proportion of the cells retaining the chromosomes by colony hybridization.
- the 853 line was grown for three months and the lines containing the acrocentric chromosomes and the control chromosome ( ⁇ Yp6) for three and five months.
- the lines containing the acrocentric chromosomes and the control chromosomes were also grown in the presence of G418 to confirm the accuracy of the assays .
- the Y chromosome and its derivatives were detected by colony lifts and filter hybridisation with either the DYZl probe and then total ⁇ Yq74 DNA (853, ⁇ Yp6, ⁇ Ypl34) or with the DXYS20 probe and total hybrid DNA.
- the figures (Table 3) indicate the proportion of colonies which hybridized to the hybrid cell DNA probe but not to the chromosome specific probe. The number of colonies in the two categories are indicated in brackets .
- Table 3 indicates that greater than 95% of the cells of each of the lines had retained the chromosomes after three months growth in the absence of applied selection. After five months growth in the absence of the antibiotic 99 of cells retained the ⁇ Yp6 chromosome, 95% of cells retained the long arm acrocentric chromosome and 86% of cells retained the short arm acrocentric chromosome. Fluorescent in si tu hybridization to chromosomes prepared from these lines at five months confirmed these figures and demonstrated that greater than 95% of the chromosomes isolated from the lines grown in the absence of selection were structurally intact (not shown) . If we assume that cells containing the chromosome grow as fast as those without the chromosome then the loss of the short arm acrocentric after five months growth in the absence of selection is consistent with this chromosome being lost once every 1,000 cell division cycles.
- the assumption of an absence of differences in growth rate is not necessarily valid given the interclonal variations in a typical cell culture and the rate of loss of the short arm acrocentric may thus be less than one loss event per thousand cell divisions.
- HT1080 is of male origin and includes a Y chromosome.
- the short arm acrocentric chromosome was transferred intact but the long arm acrocentric chromosome deleted sequences during this procedure.
- Gel electrophoresis, filter hybridization and phosphorimaging was used to assess chromosome retention after extended proliferation in the presence and absence of G418.
- Figure 7 shows filter hybridization of BamHI digests with a neo probe.
- Size markers were multimers of ⁇ cl 857 DNA.
- the alphoid DNA was intact and the chromosomes were maintained after at least four months (HT- ⁇ Yq74) or four and a half months (HT- ⁇ Ypl34) growth in the absence of G418.
- ⁇ Yq74 segregates accurately and is retained by cells for many months in the absence of selection led to further investigation of this line.
- the overall experiment with respect to ⁇ Yq74 is illustrated in Figure 9a.
- the terms DXYS20, DYZl and alphoid refer to sequences present in the chromosomes which have been indicated diagrammatically.
- the terms ADE2, svgpt and svneo refer to selectable marker genes present in the breakage constructs.
- ACTJ refers to the ARS, CEN4 and URA3 sequences present in the first round breakage construct.
- telomere directed breakage The structure of the plasmid used in the second round of telomere directed breakage is illustrated in Fig 9b; this plasmid pBSADE2svgpt TEL contains an Escherischia coli xanthine-guanine phosphoribosyl transferase gene driven by an SV40 early region promoter (Mulligan and Berg, 1981) , a Saccharomyces cerevisiae ADE2 gene (Stotz and Linder, 1990) and a 1.2kb stretch of human telomeric DNA which as previously shown (Barnett et al. , 1993) efficiently directs chromosome breakage and the formation of a new telomere in mammalian cells .
- SV40 early region promoter Mulligan and Berg, 1981
- Saccharomyces cerevisiae ADE2 gene Saccharomyces cerevisiae ADE2 gene
- 1.2kb stretch of human telomeric DNA which as
- telomeres generated by a second round of telomere directed chromosome breakage broken in four successive ways. Firstly colony hybridization with the Y short arm probe DXYS20 was used to identify clones which had deleted the centromere distal end of the ⁇ Yq74 chromosome.
- the probe was not specific for the second round breakage construct, pBSADE2svgpt TEL, but also recognized sequences used in the construction of ⁇ Yq74. As shown in Fig 13, three sites of hybridization were seen, two are on the mini-chromosome, ⁇ l and are represented by three dots, indicated with an arrow head, and one is at the end of a large hamster chromosome. The starting chromosome ⁇ Yq74 contains a single site of hybridization with this probe. It was concluded that the line containing ⁇ l contains two sites where the pBSADE2svgpt TEL has integrated; one is on the Y derived mini-chromosome ⁇ l and the other is on a hamster chromosome. Analysis of DNA extracted from the line containing ⁇ l by restriction enzyme digestion and filter hybridization confirmed that there are two sites of integration of pBSADE2svgpt TEL and that they are both telomeric.
- Pulsed field ' gel electrophoresis was used to measure the size of ⁇ l.
- DNA embedded in agarose plugs was extracted from either Schizosaccaromyces pombe cells or from cells containing ⁇ l and electrophoresed at 1 V cm" 1 in 0.6% agarose in a pulsed field gel in half strength TAE buffer at a pulse time of 90 minutes for 10 days at 4 degrees Celsius .
- the gel was then stained in a solution of ethidium bromide at 10 ⁇ g/mL for lh, rinsed in water and photographed under ultra violet light, transferred to a nylon filter and then the filter was probed with a Y chromosome alphoid DNA probe. An autoradiograph of the hybridized filter transfer was made.
- Pulsed field gel electrophoresis was also used to examine the structural stability of ⁇ l upon prolonged proliferation.
- Cells were cultured for three months and DNA was extracted at intervals of approximately 14 days as illustrated in Fig 12.
- the DNA was size fractionated by gel electrophoresis, filter transferred to nylon and analysed by hybridization with a probe specific for the alphoid DNA; ⁇ l is maintained with a constant structure.
- ⁇ Yq74 and ⁇ l were analysed for sequence tagged sites (STS) as set out in Vollrath et al. , Science (1992) , 258. 52-59 which is incorporated herein by reference, using the polymerase chain reaction (PCR) .
- STS sequence tagged sites
- ⁇ Yq74 contains sY 3 , 5, 6, 7,10, 11, 12, 13, 14, 15, 17, 18, 19, 20, 21, 22, 23, 24, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66 , 61 , 68, 69, 76 and 77. ⁇ l retains all these sitses with the exception of the more distal sequences, specifically sY 3, 5, 6, 7, 10, 11, 12, 13, 14, 15, 17, 18, 19, 20, 21, 22, 23, 24, 26, 27, 28, 29, 30, 31, 32, and 33.
- ⁇ 7, ⁇ 128 and ⁇ 196 three stable derivatives of the ⁇ Yql34 clone were obtained and designated ⁇ 7, ⁇ 128 and ⁇ 196.
- ⁇ 7 and ⁇ 128 are similar but not identical in size and are approximately 6Mb long.
- ⁇ 196 is approximately 9Mb long.
- ⁇ 7 was analysed for all these sites but it is deleted for all except sY 54, 55, 56, 88, 90, 92, 97, 98, 99,
- ⁇ 128 was analysed for all the sequences found on ⁇ Yql34 and it is deleted for all except sY 54, 55, 56, 88, 90, 92, 97, 98, 99, 104, 106, 109, 110, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 142, 143, 150, 153, 154, 155, 159, 160 and 161 which are retained.
- ⁇ l is linear mini-chromosome of approximately 8Mb in size; it is maintained stably by cells proliferating in culture and contains selectable marker genes close to each of the two telomeres.
- ⁇ l can be readily engineered to act as a vector for specific sequences by using homologous recombination to target sequences into the region of ⁇ l containing the svgpt gene.
- Sites eg the lox P site of phage PI
- site specific recombinases eg the ere recombinase of phage PI
- Sites could be targeted to ⁇ l as described above and used as targets for recombinase catalysed integration of specific sequences of interest such as plasmids or yeast artificial chromosomes .
- the recombinase could also be used to catalyse the translocation of sequences between the proposed derivative of ⁇ l and host cell chromosomes which have also been marked with a site specific recombination recognition sequence. In this way large tracts of DNA could be mobilized onto the derivative of ⁇ l.
- genes or genes complexes of clinical importance are located close to telomeres and could be mobilized onto the derivative of ⁇ l in this way. These genes include the a globin complex, the factor VIII gene and the immunoglobulin heavy chain complex.
- ⁇ l and derivatives of the types described above could be used in transgenesis of whole animals by introducing these mini-chromosomes into embryonal stem cells using either fusion or microcells (Fournier, 1981) containing ⁇ l or a derivative with embryonal stem cells.
- ⁇ l or its derivatives might be isolated from cells arrested at mitosis and introduced into embryonal stem cells by electroporation or lipofection (Feigner et al. , 1987) . In those organisms where embryonal stem cell lines have not been isolated ⁇ l or its derivatives be introduced into fertilized eggs by microinjection.
- ⁇ l or its derivatives could be used as vectors for human gene therapy by introducing the mini- chromosomes into human somatic cell types such as, but not exclusively, hepatocytes, keratinocytes, bone-marrow cells or blood cells by microcell fusion, electroporation or lipofection.
- Kearsey, S., (1983) "Analysis of sequences conferring autonomous replication in Baker's yeast", EMBO J. , 2, 1571-1575.
- Chromosomal localization of complex and repeated human DNA Chromosoma, 66 , 23-32.
- Rhoades M.M., (1938) , "On the origin of secondary trisome through the doubling of a half-chromosome fragment", Genetics, 23, 163-164.
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention relates to the field of molecular genetics and in particular to artificial chromosomes, to their preparation in particular using telomere-directed chromosome fragmentation techniques and to their use as DNA vectors, for instance for application in gene therapy and animal transgenesis. Vectors of the invention comprise a chromosome fragment which fragment is at least partly responsible for centromere function of the parent chromosome and is capable of replication and segregation during cell cycle, and which is of such a size that it can be resolved using gel electrophoresis. Suitable fragments are derived from the human Y chromosome.
Description
Novel chromosome fragment and Its use as a vector
The present invention relates to the field of molecular genetics and in particular to artificial chromosomes, to their preparation in particular using telomere-directed chromosome fragmentation techniques and to their use as DNA vectors, for instance for application in gene therapy and animal transgenesis.
Following work with yeast artificial chromosomes (YACs) , there is currently widespread interest in the prospect of building artificial chromosome vectors from other hosts such as mammals and plants, for gene therapy and animal transgenesis. In order to achieve useful mammalian artificial chromosomes (MACs) , it is necessary to generate chromosomal DNA molecules which preferably retain their linear integrity and which replicate and segregate accurately during cell cycle. It is not presently understood how large a mammalian chromosome has to be in order to achieve this, nor what DNA sequences are necessary to retain full centromere function, although the sequence requirements for mammalian telomere function are understood in outline (Barnett et al., 1993) .
In particular it is not generally understood how centromeric DNA interacts with proteins to bring about accurate chromosome segregation nor why, when much of the cell cycle is conserved (Nurse, 1990; Murray and Hunt, 1993) it varies so widely during evolution.
For instance, satellite DNA, composed of tandemly repeating sequences, is found at or close to the centromeres of many multicellular eukaryotes but has often been dismissed as being without functional significance because it is polymorphic and evolves rapidly. However human alphoid satellite DNA
(Manuelidis, 1978) has been directly implicated in centromere function by two types of observation. Alphoid DNA has been introduced into either monkey (Haaf et al., 1992) or hamster chromosomes (Heartlein and Latt, 1988) and appeared to cause the chromosomes to behave as though they were dicentric: they lagged at anaphase and were structurally unstable. The interpretation of these experiments has been controversial as the sequence organization of the integrated alphoid DNA was not described in detail, few independent integration events were analyzed and other non-centromeric sequences (Cooper and Tyler-Smith, 1992) have been reported to show similar properties (Hadlaczky et al., 1991) . A second approach to identifying human centromeric DNA has been to map centromeric sequences using re-arranged natural chromosomes; in this way Tyler-Smith and colleagues (1993) mapped the centromeric DNA of the human Y chromosome to a region which included the alphoid DNA and 300kb. of short arm flanking sequence. The observation that centromere function could be suppressed in a
"dicentric" Y chromosome by partial deletion of alphoid DNA (Tyler-Smith et al. , 1993) implicated alphoid DNA directly, although its functional significance remained undefined.
Insertional mutagenesis using existing vector systems poses problems, particularly where megabase sized fragments of DNA are to be introduced in a defined sequence environment into the genomes of humans and animals.
Use of a vector based upon a stable autonomously replicating chromosome fragment would resolve many of these problems . However it would be expected that fragments of a size which would ensure mitotic stability would too large to be isolated and manipulated in a manner required for a use in current recombinant DNA in-
vitro technology as a basis for a vector.
The present invention provides a vector comprising a chromosome fragment wliich fragment comprises sequences 5 which have centromeric activity, is capable of replication and segregation during cell cycle, and is of such a size that it can be resolved using gel electrophoresis .
10 The present invention also provides a method for obtaining a chromosome fragment for use as a vector as described above which method comprises dissecting a chromosome in such a manner that a fragment retaining centromere function is retained.
•15
Methods used in the dissection will vary depending upon the particular chromosome used and the state of knowledge regarding the structure of that chromosome and the location of the centromere region. It may be possible to
20 specifically design dissection techniques which target sites one either side of the centromere region assuming the location and nature of this region is specifically understood. However a particularly useful technique would be the application of telomere directed truncation
25 methods for example as described by Surosky and Tye, 1985 and Barnett et al., 1993. Such techniques involve the use of telomeric DNA to effect a break in the chromosome. The technique may be repeated for as often as required in order to achieve a fragment of the desired size. After
30 each step, the ability of the fragments obtained to replicate and segregate during cell cycle may be confirmed by mitosis experiments and only those which are mitotically stable to a reasonable extent selected. Techniques such as in si tu hybridisation to chromosomes
35 'in whole cells such as described in Funabiki et al. (1993) may be employed in these experiments.
Thus, a preferred method of the present invention comprises using cloned telomeric DNA to dissect a chromosome fragment containing the centromere. Suitably, this employs a pair of vectors each containing telomeric DNA, a marker gene, and chromosomal DNA from the centromeric region in opposite orientations in the two vectors, introducing the vectors into cells containing the chromosome, selecting cells which have stably integrated vector, and isolating a clone containing a chromosome derivative which has lost one arm of the chromosome but retained the other arm truncated by telomere-directed breakage within the centromeric array, such clone segregating accurately at mitosis and being retained by cells proliferating in the absence of selection.
The selected clone is then subjected to a further round of telomere-directed breakage to obtain a mini-chromosome fragment which is maintained stably by cells proliferating in culture. The second round breakage construct will suitably comprise telomeric DNA and a marker gene under the control of appropriate control agents such as promoters. An example of a suitable second round breakage construct is a linearised plasmid containing a 1.2kb stretch of human telomeric DNA, an
Escherichia coli guanine phosphoribosyl transferase gene driven by an SV40 early region promoter and a Sac char omyces cerevisiae ADE2 gene.
We have found that in this manner one can obtain a mini- chromosome fragment small enough to be resolved by gel electrophoresis.
The applicants' have identified a number of useful chromosome fragments which are derived from the human Y chromosome. The fragments are derived either from the short arm of the chromosome or the long arm of the human
Y chromosome. Preferred small fragments have been isolated from the long arm of the human Y chromosome.
Therefore in a particular embodiment, the present invention provides a vector comprising a linear derivative of the human Y chromosome which includes at least some alphoid DNA, said fragment being capable of replication and segregation during cell cycle, and capable of resolution by gel electrophoresis.
A fragment derived solely from the short arm of the human Y chromosome is approximately 8Mb in size. This fragment is suitably prepared by effecting the steps of carrying out a first telomere-directed truncation of the human Y chromosome, isolating stably segregating a fragment which contains only short arm and alphoid DNA, carrying out a second telomere-directed truncation of the isolated fragment, and isolating a shorter stably segregating fragment. A cell line containing this fragment designated Δl was deposited at the European
Collection of Animal Cell Cultures (ECACC) on 23 -May 1995 under accession number 95052342.
Fragments derived using a similar telomere directed truncation technique have been obtained from the long arm of the human Y chromosome. Fragments of approximately 6Mb in size and also as small as 3.5Mb in size are obtained in this way. The structure of these fragments has not been fully elucidated and it is believed that some form of rearrangement, possibly involving movement of the centomere takes place. However the fragments so obtained are capable of replication and segregation and their size makes them very useful as vectors. Cell lines containing three such fragments designated Δ7, Δ128 and Δ196 were deposited at the ECACC on 23 May 1995 under the accession numbers 95052343, 95052344 and 95052345 respectively.
Δ7 and Δ128 were found to be similar but not identical in size and are approximately 6Mb long. Δ196 was found to be approximately 9Mb long.
In yet a further aspect the invention comprises a vector as described above into which a gene encoding a desired protein has been incorporated. Furthermore the invention provides a cell transformed using a vector as described above.
Yet further the invention provides a method of carrying out gene therapy which comprises forming a vector as described above including a desired gene and incorporating the said vector into the host cells.
By using the chromosome fragments as a basis for DNA vectors, the problems of insertional mutagenesis can be overcome. In particular, they will allow long tracts of DNA, potentially including multiple genes into hosts, suitably mammals or cells in tissue culture. Such vectors, being accurately reproduced during many generations, are extremely advantageous.
As used herein, the expression capable of 'replication and segregation during cell cycle' means that the DNA is accurately replicated and segregated for at least 100 and suitably at least 500 cell divisions and that preferably the chromosome is lost no more than once every 200 cell divisions suitably no more than once every 1000 cell divisions.
In addition, when a fragment is said to be resolved by gel electrophoresis, it is generally expected that this will have a size of no more than about 10Mb. Suitably fragments of this size or less, preferably 6.0Mb or less and more preferably 3.5Mb or less, are used as the basis of DNA vectors.
The invention will now be particularly described by way
of example with reference to the attached Figures in which
Figure 1 shows the design of initial targeting experiment to dissect the centromere region of the human Y chromosome with telomeres;
Figure 2 illustrates the progress of the experiment of Figure 1;
Figure 3 shows the results of an analysis of two cell lines obtained in the experiment by fluorescent in si tu hybridisation,*
Figures 4a-4c show the results of molecular studies carried out on the cell lines of Figure 3;
Figures 5a-5b show the mapping of the EcoRI and Xbal sites flanking the constructs in the cell lines;
Figures 6a-6c show the results of fluorescent in situ hybridisation experiments looking at the mitotic behaviour of the Y chromosome and the derivatives;
Figure 7 demonstrates the stable inheritance of one of the cell line and of a deleted derivative of the second;
Figure 8 illustrates the kinetics of variant accumulation in a culture of dividing cells;
Figure 9a and 9b illustrate the design of an experiment to further dissect one of the derivatives and the structure of the plasmid used in this experiment respectively;
Figure 10 illustrates the progress of the second step of the experiment of Figure 9a;
Figure 11 shows a map summary of the desired Δl fragment;
Figure 12 illustrates the stability of the final fragment obtained.
Figure 13 shows fluorescent in situ hybridization of chromosomes isolated from the cell line containing Δl; and
Figure 14 shows pulsed field gel analysis of DNA extracted from the cell line containing Δl and from Schizosaccharomyces pombe.
As mentioned above, the applicants have been using cloned telomeric DNA (Barnett et al. 1993) to dissect the human Y chromosome of defined structure (Brown et al. submitted for publication) . The design of this work is illustrated in Figure la. The 853 mono-chromosome somatic cell hybrid line (Burk et al. 1985) was used as the source of human Y chromosome. This cell line is hprt- and will not grow in medium containing hypoxantine, aminopterin and thymidine (HAT) . In experiments described in detail below, a plasmid containing a 5.7kb fragment of Y chromosome derived alphoid DNA (Tyler-Smith and Brown, 1987), a gene encoding resistance to the antibiotic G418, a 1.2kb stretch of cloned telomeric DNA (Barnett et al. , 1993) , and a cassette to allow recovery of flanking sequences in Saccharomyces cerevisiae was introduced into 853 cells. Cells which had stably integrated the plasmid were selected and one clone isolated which contained a Y chromosome derivative, called ΔYq74, which had lost the long arm of the human Y chromosome, retained the short arm and which had been truncated by telomere directed breakage within the -centromeric array of alphoid DNA. Extensive analysis established that ΔYq74 segregates accurately at mitosis and is retained by cells proliferating for many months in the absence of
selection .
Cells containing ΔYq74 were taken and ΔYq74 broken in a second round of telomere directed breakage. A novel fragment or mini-chromosome designated Δl was produced. This was found to be a linear mini-chromosome of about 8Mb in size which could be separated using gel electrophoresis. It is maintained stably by cells proliferating in culture and contains selectable marker genes close to each of the two telomeres.
The following Examples illustrate an embodiment of the invention. In these examples, the following cell culture techniques were employed throughout.
853 cells (Burk et al. , 1985), HT1080 cells (Rasheed et al, 1974) and cells containing the truncated chromosomes were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% Foetal Calf Serum as described in the art (Barnett et al. , 1993) .
Electroporation was also as described (Barnett et al. , 1993) . The protocol for colony hybridization was that of Avraham et al. (1989) except that Hybond nylon membranes were used. Clones to be identified by colony hybridization were originally plated out at about 200 colonies per 9 cm. plate and were subsequently purified by three further rounds of colony hybridization and cloning.
In order to confirm the stability of the clones, the microcell fusion protocol of Fournier (1981) was used except that microcells were separated from donor cells by centrifugation of colcemid treated donor cells for 70 minutes at 35,000g in a 1:1 mixture of Percoll (Pharmacia) and DMEM with 10% Foetal Calf Serum which contained Cytochalsin B at lOμg./ml. Two microcell containing bands formed and were aspirated from the
gradient and the microcells, were harvested by centrifugation at l,000g for 15 minutes and then filtered successively through 8/ιm and 5μm polycarbonate filters. Recipient cells were washed twice in phosphate buffered saline, incubated with the microcells for 15 minutes at 37°C in PBS containing Phytohaemagglutinin at lOμg/ml. The supernatant was then gently removed and the cells, coated with the microcells, were incubated in 50% polyethylene glycol 1500 in serum free DMEM for two minutes at 37°C. The cells were washed twice with serum free medium and then incubated for 10-15 minutes at 37°C in serum free medium. The cells were then incubated overnight in DMEM containing FCS, split and selection was applied.
Typically 200μg/ml. G418 was used to select for either HT1080 or 853 derivative cells carrying the G418 resistance gene.
Example 1
Targeting and Cloning of Chromosome Fragments
In an initial targeting experiment (Fig 1) the 853 monochromosomal somatic cell hybrid line (Burk et al., 1985) was used as the source of the human Y chromosome. These cells proliferate quickly in culture and the absence of other human chromosomes in the hybrid make it easy to detect Y chromosome derivatives in a clone of cells . There is a single array of alphoid DNA at the centromere of the human Y chromosome (Tyler-Smith and Brown, 1987) . The orientation of the array is known (Cooper et al, 1993) and is indicated by the positions of the EcoRI and Xbal sites which occur once and twice respectively in each 5.7kb unit. Two targeting plasmids (A and B in Fig. 1) were constructed each containing a
5.7kb EcoRI fragment of Y chromosome DNA cloned from the alphoid array (Tyler-Smith and Brown (1987) , a gene encoding resistance to the antibiotic G418, a 1.2kb stretch of cloned telomeric DNA (Barnett et al., 1993) and a cassette to allow recovery of flanking sequences in S. cerevisiae.
The G418 resistance gene used in the constructs was 2.2kb Accl-BamHI fragment of pSV2neo (Mulligan and Berg, 1980) . The fragment used in the targeting constructs to allow shuttling into S. cerevisiae was constructed from the URA3 containing Sal-lXhol fragment of pYAC4 (Burke et al., 1987) the CEN4 containing HpalClal fragment of pYAC4 and an ARS sequence contained in a 500bp Sstll-Hindlll fragment of the HO endonuclease gene (Kearsey, 1983) .
The human telomeric sequences were contained in the 1.2kb Taql fragment described in Barnett et al. (1993) .
The alphoid DNA in the appropriately linearized plasmid was intended to target it to the alphoid array and the telomeric DNA acts to cause chromosome breakage. The two plasmids differ in the respective orientations of the 5.7kb alphoid units and thus targeted breakage of the Y chromosome by these plasmids was expected to generate derivative chromosomes of reciprocal structures.
The 853 cells were transfected with either of the linearized targeting plasmids A or B and screened in three successive ways for clones which contained Y chromosomes broken within the alphoid DNA. Firstly colony hybridization with Y long arm (DYZ1) and Y short arm (DXYS20) specific probes was used to identify clones which have deleted either all or part of either the long or short arms of the chromosome. Secondly gel electrophoresis and filter hybridization was used to other Y chromosome probes to map the extent of the deletions. Filter hybridization and gel electrophoresis
were carried out as described in Barnett et al. , (1993) . Finally in si tu hybridization with a probe specific for the breakage construct was used to determine which clones contained autonomous chromosomes that had been truncated by the targeting constructs. In this way 24 clones were isolated (Fig 2) which were truncated on either the long arm or short arms by telomeric DNA. The sequence content of these clones was determined by gel electrophoresis and filter hybridisation. These are is indicated in Table 1 where 'T' represents truncation of the centromeric alphoid array; 'R' represent a rearrangement characterized by the presence of two cognate large BamHI fragment, '+' indicated that the locus is present and '-' indicates that the locus is absent.
The remaining clones which hybridized differentially to DXYS20 and DYZl contained Y chromosome fragments that had either integrated into or translocated onto hamster chromosomes.
Probes used in the analysis of the Y chromosomes were as follows; 29cl for the telomere of Yp (Cooke et al. , 1986) , 62RI (Brown, 1988), ZFY (Page et al. , 1987), 115i (DXYS8) and pl6(DXYS6), (Geldwerth et al. , 1986) the 4.5kb Hindlll fragment of Y190 (DYZ5; Tyler-Smith et al. , 1988) pDP34 (DXYS1) (Page et al. , 1984) 50f2, 52d and 64a, (Guellan et al. , 1984), 21A1 (DYZ8; Arnemann et al. , 1987) , GMGY6 and GMGXY3 (Affara et al. , 1986) 43/2 and 20/3, oxYl (Oakey and Tyler-Smith, 1990) and TelBam3.4 for the telomere of Yq (Brown et al. , 1990) .
In si tu hybridisation of biotin labelled probes to metaphase chromosomes was as described by Buckle and Rack (1993) .
One member of each of the short arm and of the long arm deletion series had lost either the entire short arm or
long arm and contained a single alphoid DNA array which was smaller than that of the starting chromosome. These chromosomes; ΔYpl3 and ΔYq74, were thus candidates for chromosomes which had been targeted and broken in the alphoid array. The results of an analysis of these lines by fluorescent in si tu hybridization are illustrated in Fig. 3. Probing chromosomes of either the original 853 line, the ΔYq74 clone or the ΔYpl34 clone with human genomic DNA detected a single autonomous chromosome. A Y chromosome alphoid DNA probe identified a single locus of hybridization on a chromosome identical in size and appearance to the one identified by the human genomic DNA probe. The alphoid signal was at primary constriction of the Y chromosome and at or close to the end of ΔYq74 or ΔYpl34. A probe for the breakage construct, lacking alphoid and telomeric components, specifically stained both ΔYq74 or ΔYpl34.
Molecular studies illustrated in Fig 4 confirmed and extended the results of the in si tu hybridization.
The work giving rise to Fig 4 was carried out as follows:
Fig 4a. The alphoid DNA was truncated and on the same restriction fragment as the targeting construct in ΔYq74 and ΔYpl34.
DNA extracted from either 853 cells or from cells containing ΔYq74 or ΔYpl34 was restricted with the indicated enzyme, the digests were analysed by pulsed field gel electrophoresis and filter hybridization with a neo probe specific for the targeting construct and then with a Y alphoid probe. Markers are oligomers of λcI857 DNA.
Fig 4b. The targeting constructs have seeded new telomeres in ΔYq74 and ΔYpl34. DNA extracted from either
1 Δ.
ΔYq74 or ΔYpl34 was digested in solution with Bal31 for progressively increasing lengths of time and then with Hindlll. Digests were analysed by gel electrophoresis and filter hybridization with a probe specific for the S. cerevisiae CEN4 sequence in each construct.
Fig 4c. The long range organization of the alphoid DNA in ΔYq74 and ΔYpl34. The restriction site mapping illustrated in A was extended and sites for the indicated enzymes placed in the DNA flanking the alphoid DNA in the original Y, ΔYq74 and ΔYpl3 to produce the map.
DNA from the 853 and ΔYq74 and ΔYpl34 cell lines was restricted with six enzymes that do not cut within the alphoid DNA array and analyzed by filter hybridization after gel electrophoresis (Fig 4a) as described by Barnett et al., (1993) . Each chromosome contained a single alphoid DNA fragment which was smaller in ΔYq74 and ΔYpl34 than in the original cell line. For example the Bglll fragment derived from the 853 line was 550kb long and the fragments derived from the ΔYq74 and. ΔYpl34 lines were 145kb and 480kb long respectively. The alphoid fragments in the derived lines hybridized to a probe specific for the breakage construct demonstrating that the breakage constructs had integrated into the alphoid DNA (Fig 4a) . The telomeric location of the targeting constructs in ΔYq74 and ΔYpl34 was confirmed by demonstrating their sensitivity to Bal31 exonuclease digestion (Fig 4b) . The restriction site mapping experiments initiated in Fig 4a were extended and positioned the sites for other enzymes in the DNA flanking the alphoid arrays . Restriction site mapping confirmed that the constructs were intact. These maps were combined to produce a map (Fig. 4c) of the DNA flanking array in the original chromosome. The map was identical to the one generated in previous work (Tyler- Smith, 1987) using double digests and thus these results
combine with the deletion analysis to indicate that the truncations have not been accompanied by other rearrangements. The restriction site mapping also established that ΔYq74 and ΔYpl34 hold 70kb of DNA of their respective alphoid arrays in common.
Each 5.7kb alphoid unit contains a single EcoRI site and a pair of Xbal sites. These positions of these sites are known and they can be used to orient individual units . In order to determine whether the constructs had integrated into the alphoid DNA by homologous recombination and whether the DNA held in common by ΔYq74 and ΔYpl34 was likely to be exclusively alphoid, the EcoRI and Xbal sites flanking the constructs in ΔYq74 and ΔYpl34 (Fig. 5) were mapped.
DNA from either ΔYq74 or ΔYpl34 was digested to completion with Bglll, partially restricted with either EcoRI or Xbal and analysed by gel electrophoresis and filter hybridization with a neo probe, illustrated in Figure 5a.
Restriction site maps deduced from Fig. 5a are shown in Fig. 5b. There are a number of unresolved bands at about 23kb in the second track of ΔYq74 in A. The number of Xbal sites represented in the unresolved cluster is either three or four and has been arbritarily indicated as four. The alphoid arrays in the top and bottom panels are not aligned.
Analysis of the ΔYq74 DNA established that the construct had not integrated into the genomic DNA by a simple homologous recombination event as it appeared that three 5.7kb alphoid units flanking the integrated construct in the ΔYq74 cell line had inverted with respect to their usual orientation. The ΔYpl34 mapping results were more straightforward and were consistent with the construct
having integrated by a simple homologous recombination event. The sizing on the blot in Fig. 5a is imprecise however and we cannot be sure of such a mechanism without sequence data. The maps of the DNA for 40kb flanking each construct are also consistent with this DNA being alphoid DNA and thus these data also indicate that the 70kb held in common by ΔYq74 and ΔYpl3 is alphoid.
Example 2
Examination of Mitotic Behaviour
Fluorescent in si tu hybridization to whole anaphase cells was used to examine the mitotic behaviour of the Y chromosome and the truncated derivatives. The techniques used was modified from the protocol developed by Funabiki et al. (1993) . The cells were grown for 36-48 hours after plating onto 22mm square coverslips, rinsed in PBS and then simultaneously fixed and permeabilised by a 30min. incubation in 20mM potassium phosphate, 130mM
NaCl, 20mM KCI, lOmM EDTA, 2mM MgCl2, 0.1% Triton X-100 and 0.5% glutaraldehyde (EM Grade from Polysciences) , pH7.3 at room temperature. The cells on the coverslip over rinsed three times with PBS and incubated twice with lmg/ml NaBH4 in dH20, washed twice in PBS and incubated for 30 minutes in 5% normal goat serum in PBS. The cells were then washed four times in PBS and fixed a second time by incubation in 50mM ethylene glycol bis- (succinimidylsuccinate) in PBS for 30 minutes at 37°C. After washing in PBS the coverslips were incubated in lOOμg/ml. RNAase A in PBS at 37°C for one hour and then rinsed again in PBS. The DNA was denatured by a four minute incubation in 0.2M NaOH at room temperature and the coverslips were flooded with PBS. The coverslips were then plunged into ice cold PBS and then hybridized in si tu with biotinylated probe as described by Buckle and Rack (1993) and finally washed in SSC at 37°C.
Detection was as described by Buckle and Rack (1993) and images were collected on a MRC 600 confocal microscope and transferred to a Titan 3000 workstation for manipulation and display. 3D projections were calculated and displayed using the software described by Highett and colleagues (1993) .
Fig 6a shows anaphase segregation of the intact Y chromosome in the 853 cell line, Fig 6b shows segregation of ΔYq74 and Fig 6c shows what we saw most often with ΔYpl34. In about 10% of the mitotic cells (see figure legend for numbers) ΔYpl34 specifically lagged with respect to the other chromosomes and a particularly extreme example is seen in Fig 6d (a telophase cell) . We examined about 1,000 anaphase and early telophase cells of each of the cell lines containing either the original Y, ΔYq74 and ΔYpl34 or the chromosome ΔYp6 which is truncated at the tip of the short arm and which serves to control for any effect that the breakage construct may have upon the behaviour of the chromosome (Table 2) . No cells were observed in which both Y chromatids segregated to a single pole (2:0 events) and it was thus concluded that each of the four chromosomes was segregating accurately. Although about 10% of the ΔYpl34 cells contained a lagging chromatid, all of those seen in the sample 985 cells had separated from their sisters and appeared to be moving to opposite poles. It was estimated that about 10,000 anaphase and telophase ΔYpl34 cells were seen in the course of all experiments and in only two of these did it appear possible that the chromatids were not about to end up in different daughter cells. Between 1% and 5% of the cells contain four chromatids segregating in a 1:1 ratio; analysis of metaphase chromosomes established the presence of similar percentages of tetraploid cells with two chromosomes in the lines; suggesting that the cells with four chromatids were tetraploid cells which may have arisen through
occasional endoreduplication events. Between 2% and 5% of the cells did not contain chromosomes detectable by in si tu hybridization. These cells appear to have arisen from a failure of the probe to enter the cells because the cultures were also analyzed by colony hybridization to total human genomic DNA and found that greater than 99% of the colonies hybridized specifically. Between 0% (ΔYp6) and 1.1% (ΔYpl3 ) of the cells in these lines contained odd numbers of chromatids . These cells may have arisen from either a detection failure or a failure of chromosome replication. Examination of the DAPI stained chromosomes in the same figures revealed no chromatids outside the polar group of hamster suggesting that hone of these cells contained inaccurately segregating chromatids .
Given a sample size of 1,000 there is a greater than 95% probability that we would have detected an inaccurate segregation event if such events were occurring at a frequency of greater than 1 in 300 and so we can say at this level of precision that the intact Y chromosome, ΔYp6 and the ΔYq74 and ΔYpl34 chromosomes are segregating accurately. These results therefore demonstrate that the ΔYq74 and ΔYpl3 have functional centromeres and we shall henceforth refer to them as, respectively, the short arm and long arm acrocentric derivatives of the Y chromosome.
The relative stability of the chromosomes in mitotically proliferating cells was determined by growing cells in the absence of applied selection and measuring the proportion of the cells retaining the chromosomes by colony hybridization. The 853 line was grown for three months and the lines containing the acrocentric chromosomes and the control chromosome (ΔYp6) for three and five months. The lines containing the acrocentric chromosomes and the control chromosomes were also grown in the presence of G418 to confirm the accuracy of the
assays . The Y chromosome and its derivatives were detected by colony lifts and filter hybridisation with either the DYZl probe and then total ΔYq74 DNA (853, ΔYp6, ΔYpl34) or with the DXYS20 probe and total hybrid DNA. The figures (Table 3) indicate the proportion of colonies which hybridized to the hybrid cell DNA probe but not to the chromosome specific probe. The number of colonies in the two categories are indicated in brackets .
Table 3 indicates that greater than 95% of the cells of each of the lines had retained the chromosomes after three months growth in the absence of applied selection. After five months growth in the absence of the antibiotic 99 of cells retained the ΔYp6 chromosome, 95% of cells retained the long arm acrocentric chromosome and 86% of cells retained the short arm acrocentric chromosome. Fluorescent in si tu hybridization to chromosomes prepared from these lines at five months confirmed these figures and demonstrated that greater than 95% of the chromosomes isolated from the lines grown in the absence of selection were structurally intact (not shown) . If we assume that cells containing the chromosome grow as fast as those without the chromosome then the loss of the short arm acrocentric after five months growth in the absence of selection is consistent with this chromosome being lost once every 1,000 cell division cycles.
The simple model used in the interpretation of the cell culture data is illustrated in Figure 8. In this figure, the filled circles represent type A cells which contain a chromosome and the empty circles correspond to variant B cells which lack a chromosome. It was considered that parental line, termed A, divides with a first order rate k1# it generates variants called B with a rate constant k2 which in turn divide with a first order rate given by k3. For small values of k2 the following equation should apply:
dA/dt =k1A ;
dB/dt=k2A+k3B
If A0 is defined as the number of cells at t=0 then this pair of equations has three solutions according to the relative values of k: and k3. The simplest assumption is that the A and B cells divide at the same rate; ie k, =k3 and this leads to the solution for small values of B that:
A=A0eklc and B/A=k2t.
These expressions were used in extrapolating the rate of chromosome loss per cell division from the results of the experiments where the cells were grown in the absence of selection and then measured the amount of chromosome loss. The rate at which both the 853 cells and the HT1080 cells double is once every day and so the value of kiis taken as Id"1.
The assumption of an absence of differences in growth rate is not necessarily valid given the interclonal variations in a typical cell culture and the rate of loss of the short arm acrocentric may thus be less than one loss event per thousand cell divisions.
The acrocentric chromosomes were transferred to the human cell line HT1080 using microcells in order to exclude the possibility that the retention of the chromosomes in the hybrid cells reflected complementation of a recessive defect in the Chinese hamster chromosomal background. HT1080 is of male origin and includes a Y chromosome. The short arm acrocentric chromosome was transferred intact but the long arm acrocentric chromosome deleted sequences during this procedure. Gel electrophoresis, filter hybridization and phosphorimaging was used to
assess chromosome retention after extended proliferation in the presence and absence of G418. Figure 7 shows filter hybridization of BamHI digests with a neo probe. Size markers were multimers of λcl 857 DNA. The alphoid DNA was intact and the chromosomes were maintained after at least four months (HT-ΔYq74) or four and a half months (HT-ΔYpl34) growth in the absence of G418. In order to measure the rate of loss of the experimental chromosomes relative to the rate of loss of the Y chromosome in the parental line we reprobed the filter illustrated in Figure 7 with an alphoid probe and determined the relative intensities of the signals due to the host and donor Y chromosomes,* comparison of these values before and after growth indicated that the short arm acrocentric ΔYq74 was retained but that about a third of the deleted derivative of the long arm acrocentric had been lost, suggesting a rate of loss of this chromosome of about once every 500 cycles of cell division.
Example 3
Further Telomere-directed Truncation of ΔYq74
The observation that ΔYq74 segregates accurately and is retained by cells for many months in the absence of selection led to further investigation of this line. The overall experiment with respect to ΔYq74 is illustrated in Figure 9a. The terms DXYS20, DYZl and alphoid refer to sequences present in the chromosomes which have been indicated diagrammatically. The terms ADE2, svgpt and svneo refer to selectable marker genes present in the breakage constructs. The letters ACTJ refers to the ARS, CEN4 and URA3 sequences present in the first round breakage construct.
The structure of the plasmid used in the second round of
telomere directed breakage is illustrated in Fig 9b; this plasmid pBSADE2svgpt TEL contains an Escherischia coli xanthine-guanine phosphoribosyl transferase gene driven by an SV40 early region promoter (Mulligan and Berg, 1981) , a Saccharomyces cerevisiae ADE2 gene (Stotz and Linder, 1990) and a 1.2kb stretch of human telomeric DNA which as previously shown (Barnett et al. , 1993) efficiently directs chromosome breakage and the formation of a new telomere in mammalian cells .
The progress of the experiment is summarized in Fig. 10. "In situ hybridization" refers to analysis by fluorescent in situ hybridization to metaphase chromosomes as described by Buckle and Rack (1993) .
Cells containing ΔYq74 were transfected with the plasmid pBSADE2svgpt TEL which had been linearized so that the telomeric DNA was located at one end of the construct, selected for stably transfected clones using HAT and screened for clones which contained mini-chromosomes generated by a second round of telomere directed chromosome breakage broken in four successive ways. Firstly colony hybridization with the Y short arm probe DXYS20 was used to identify clones which had deleted the centromere distal end of the ΔYq74 chromosome. Secondly fluorescence in si tu hybridization with a Y chromosome alphoid DNA probe was used to identify clones containing small autonomous chromosome derivatives of the original ΔYq74 chromosome,* this led to the identification of 16 chromosomes. Thirdly gel electrophoresis and filter hybridization to other Y chromosome short arm probes was used to map the extents of the deletions and to detect any rearrangements in this set of 16 clones (Table 4) . Finally fluorescent in si tu hybridization to metaphase chromosomes with a probe for the breakage construct was used to determine which clones contained autonomous chromosomes that had been truncated by the second round
breakage construct. In this way we isolated one clone which contained a chromosome Δl, which was truncated by the integration of the second round breakage construct pBSADE2svgpt TEL into ΔYq74. The remaining clones contained Y chromosome fragments rearranged by other undefined mechanisms. A final FISH analysis of the clone containing the Δl chromosome was carried out (see Fig 13) . Metaphase chromosomes of the hybrid somatic cell line containing Δl were hybridized in situ with a probe recognising the svgpt gene, the SVneo gene and the S. cerevisiae components in the breakage constructs used to generate Δl. The probe was not specific for the second round breakage construct, pBSADE2svgpt TEL, but also recognized sequences used in the construction of ΔYq74. As shown in Fig 13, three sites of hybridization were seen, two are on the mini-chromosome, Δl and are represented by three dots, indicated with an arrow head, and one is at the end of a large hamster chromosome. The starting chromosome ΔYq74 contains a single site of hybridization with this probe. It was concluded that the line containing Δl contains two sites where the pBSADE2svgpt TEL has integrated; one is on the Y derived mini-chromosome Δl and the other is on a hamster chromosome. Analysis of DNA extracted from the line containing Δl by restriction enzyme digestion and filter hybridization confirmed that there are two sites of integration of pBSADE2svgpt TEL and that they are both telomeric.
Example 4
Size fractionation and stability of Δl by pulsed field gel electrophoresis.
Pulsed field 'gel electrophoresis was used to measure the size of Δl. We size fractionated DNA extracted from cells containing Δl together with DNA extracted from the yeast Schizosaccharomyces pombe and analysed the size
fractionated DNA either by ethidium bromide staining and photography (Figure 14A) or by hybridization with a Y chromosome alphoid probe after filter transfer (Figure 14B) . DNA embedded in agarose plugs was extracted from either Schizosaccaromyces pombe cells or from cells containing Δl and electrophoresed at 1 V cm"1 in 0.6% agarose in a pulsed field gel in half strength TAE buffer at a pulse time of 90 minutes for 10 days at 4 degrees Celsius . The gel was then stained in a solution of ethidium bromide at 10 μg/mL for lh, rinsed in water and photographed under ultra violet light, transferred to a nylon filter and then the filter was probed with a Y chromosome alphoid DNA probe. An autoradiograph of the hybridized filter transfer was made.
The relative mobilities of the hybridizing fragment in Figure 14B and of the S. pombe chromosomes which are of known size (Fan et al, 1988) indicated that the Δl chromosome is approximately 8Mb in size.
The results are summarized in the map of Δl illustrated in Fig 11. As noted earlier the human Y chromosome has been extensively mapped (Foote et al., 1992) and it is possible to estimate the approximate positions on Δl of some of the sequences used in the analysis of Δl indicated in Table 1.
Pulsed field gel electrophoresis was also used to examine the structural stability of Δl upon prolonged proliferation. Cells were cultured for three months and DNA was extracted at intervals of approximately 14 days as illustrated in Fig 12. The DNA was size fractionated by gel electrophoresis, filter transferred to nylon and analysed by hybridization with a probe specific for the alphoid DNA; Δl is maintained with a constant structure.
ΔYq74 and Δl were analysed for sequence tagged sites
(STS) as set out in Vollrath et al. , Science (1992) , 258. 52-59 which is incorporated herein by reference, using the polymerase chain reaction (PCR) . It was found that ΔYq74 contains sY 3 , 5, 6, 7,10, 11, 12, 13, 14, 15, 17, 18, 19, 20, 21, 22, 23, 24, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66 , 61 , 68, 69, 76 and 77. Δl retains all these sitses with the exception of the more distal sequences, specifically sY 3, 5, 6, 7, 10, 11, 12, 13, 14, 15, 17, 18, 19, 20, 21, 22, 23, 24, 26, 27, 28, 29, 30, 31, 32, and 33.
Example 5 Further Telomeric-directed Truncation of ΔYql34
Using methods anologous to those described in Example 3 and Example 4, three stable derivatives of the ΔYql34 clone were obtained and designated Δ7, Δ128 and Δ196. Δ7 and Δ128 are similar but not identical in size and are approximately 6Mb long. Δ196 is approximately 9Mb long.
Analysis of ΔYql34, Δ 7, Δ128 and Δ196 for the long arm sequence tagged sites have found that ΔYql34 contains sY
53, 54, 55, 56, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88,
90, 92, 93, 94, 97, 98, 99, 100, 101, 102, 103, 104, 105,
106, 107, 108, 109, 110, 111, 113, 115, 116, 117, 118,
119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140,
142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152,
153, 154, 155, 157, 158, 159, 160 and 161.
Δ 7 was analysed for all these sites but it is deleted for all except sY 54, 55, 56, 88, 90, 92, 97, 98, 99,
106, 109, 110, 129, 130, 131, 132, 133, 134, 135, 136,
137, 138, 139, 140, 142, 143, 150, 153, 154, 155, 159,
160 and 161 which are retained.
Similarly Δ128 was analysed for all the sequences found on ΔYql34 and it is deleted for all except sY 54, 55, 56, 88, 90, 92, 97, 98, 99, 104, 106, 109, 110, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 142, 143, 150, 153, 154, 155, 159, 160 and 161 which are retained.
Analysis of Δ196 in a similar manner showed that all the STS sequences present on ΔYql34 were deleted with the exception of sY 79, 81, 82, 83, 84, 85, 86, 87, 88, 90, 92, 93, 94, 97, 98, 99, 100, 101, 102, 151 and 161.
All chromosome fragments retain the alphoid DNA and are therefore positive for sY78.
Example 6
Vector production
Δl is linear mini-chromosome of approximately 8Mb in size; it is maintained stably by cells proliferating in culture and contains selectable marker genes close to each of the two telomeres. Δl can be readily engineered to act as a vector for specific sequences by using homologous recombination to target sequences into the region of Δl containing the svgpt gene. Sites (eg the lox P site of phage PI) for the site specific recombinases (eg the ere recombinase of phage PI) could be targeted to Δl as described above and used as targets for recombinase catalysed integration of specific sequences of interest such as plasmids or yeast artificial chromosomes . This would be a specific example of a general use of such site specific recombinases proposed by other (Fukushige and Sauer, 1992) . The recombinase could also be used to catalyse the translocation of sequences between the proposed
derivative of Δl and host cell chromosomes which have also been marked with a site specific recombination recognition sequence. In this way large tracts of DNA could be mobilized onto the derivative of Δl.
Similar considerations will apply to Δ7, Δ128 and Δ196 in terms of their use as vectors.
Several human genes or genes complexes of clinical importance are located close to telomeres and could be mobilized onto the derivative of Δl in this way. These genes include the a globin complex, the factor VIII gene and the immunoglobulin heavy chain complex.
Δl and derivatives of the types described above could be used in transgenesis of whole animals by introducing these mini-chromosomes into embryonal stem cells using either fusion or microcells (Fournier, 1981) containing Δl or a derivative with embryonal stem cells. Alternatively Δl or its derivatives might be isolated from cells arrested at mitosis and introduced into embryonal stem cells by electroporation or lipofection (Feigner et al. , 1987) . In those organisms where embryonal stem cell lines have not been isolated Δl or its derivatives be introduced into fertilized eggs by microinjection.
Similarly Δl or its derivatives could be used as vectors for human gene therapy by introducing the mini- chromosomes into human somatic cell types such as, but not exclusively, hepatocytes, keratinocytes, bone-marrow cells or blood cells by microcell fusion, electroporation or lipofection.
Although the techniques have been applied with respect to the human Y chromosome, the skilled person would understand that other chromosomes, in particular plant
chromosomes, could be subjected to similar analysis techniques and form the basis of related vectors. For example, it is known from the study of breaks induced in chromosomes by X-rays that it is possible to subdivide plant centromeres (McClintock, 1932) . Subsequent studies have supported this observation (Rhodes, 1938; Darlington, 1940) and led to the idea that functional entities of centromeres were repeated. This means that fragments of the required size and with the required centromeric function could be obtained from plant chromosomes using similar reaction strategies to those described above.
References
Affara et al (1986) , "Regional Assignment of Y linked DNA probes by deletion mapping and their homology with X- chromosome and autosomal sequences", Nucl. Acid Res., 14, 5353-5373.
Arnemann et al (1985) , "Human Y chromosome derived cloned DNA sequences", Cytogenet . Cell Genet., 40, 571.
Avraham et al, (1989) , "A Rapid Procedure for Cell Colony Hybridization using DNA probes", Anal. Biochem., 179, 217-221.
Barnett et al, (1993) , "Telomere directed fragmentation of Mammalian Chromosomes", Nucl. Acid Res. 21, 27-36.
Brown, W.R.A., (1988) , "A physical map of the human pseudoautosomal region", EMBO J., 7, 2377-2385.
Brown, W.R.A. , (1992) , "Mammalian artificial chromosomes", Current Opinion in Genetics and Development, 2, 479-486.
Brown et al, (1990) , "Structure and polymorphism of Human telomere-associated DNA", Cell 63, 119-132.
Buckle et al, (1993) , "Fluorescent in situ hybridization in Human Genetic Disease Analysis", (2nd Edition); ed K.E. Davies, IRL Press.
Burk et al, (1985) , "Characterization of a single copy sequence from the human Y chromosome", Mol. Cell. Biol., 5, 576-581.
Burke et al, (1987) , "Cloning of large segments of exogenous DNA by means of artificial chromosome vectors",
Science 236 , 806 - 812 .
Cooke, H.J., (1976) , "A repeated sequence specific for human males", Nature, 262, 182-186.
Cooke et al, (1985) , "Hypervariable telomeric sequences from the human sex chromosomes are pseudoautosomal" , Nature, 317, 687-692.
Cooper et al, (1992) , "The putative centromere forming sequence CM8 is a single copy sequence and not a component of most centromeres", Hum. Molec. Gen., 1, 753- 754.
Cooper et al (1993a) , "Structure of the sequences adjacent to the centromeric alphoid satellite DNA on the human Y chromosome", J. Mol. Biol. , 230, 787-799.
Cooper et al, (1993b) , "The major centromeric array of alphoid satellite DNA on the human Y chromosome is non- palindromic" , Human. Molec. Gen., 2, 1267-1270.
Darlington, CD. (1940) , "The origin of Iso-Chromosomes" , J. Genet., 39, 351-361.
Fan et al, (1988), Nucleic Acids Res., 17, 2801-2818
Feigner et al, (1987) , "Lipofection: A highly efficient, lipid mediated DNA-transfection procedure", Proc. Natl. Acad. Sci. (USA), 84, 7413-7417.
Foote et al, (1992), "The human Y chromosome: overlapping clones spanning the euchromatic region", Science, 258, 60-66.
Fournier, R.'E.K. (1981) , "A general high-efficiency procedure for production of microcell hybrids", Proc.
Natl. Acad. Sci. (USA) , 78, 6349-6353.
Funabiki et al, (1993) , "Cell cycle dependent specific positioning and clustering of centromeres and telomeres in Fission Yeast", J. Cell. Biol., 121, 961-976.
Fukushige et al, (1992) , "Genomic targeting with a positive-selection/ox integration vector allows highly reproducible gene expression in mammalian cells", Proc. Natl. Acad. Sci. (USA) , 89, 7905-7909.
Geldwerth et al, (1985) , "Extensive DNA sequence homologies between the human Y chromosome and the long arm of the X chromosome", EMBO J., 4, 1739-1743.
Guellan et al, (1984) , "Human XX males with Y single copy DNA fragments", Nature, 307, 172-173.
Highett et al, (1993), "Different Patterns of rDNA distribution in Pisum sativum correlate with different levels of nuclear activity", J. Cell Sci., 104, 843-852.
Guellan et al, (1984) , "Human XX males with Y single copy DNA fragments", Nature, 307, 172-173.
Haaf et al, (1992) , "Integration of human a satellite DNA into simian chromosomes; centromere protein binding and disruption of normal chromosome segregation", Cell, 70, 681-696.
Hadlaczky et al, (1991) , "Centromere formation in mouse cells cotransformed with human DNA and a dominant selectable marker", Proc. Natl. Acad. Sci., (USA), 88, 8106-8110.
Heartlein et al, (1988) , "Chromosome instability associated with human alphoid DNA transfected into the
Chinese hamster genome", Mol. Cell. Biol. 8, 3611-3618.
Kearsey, S., (1983) , "Analysis of sequences conferring autonomous replication in Baker's yeast", EMBO J. , 2, 1571-1575.
Manuelidis, L. , (1978), "Chromosomal localization of complex and repeated human DNA", Chromosoma, 66 , 23-32.
McClintock, B., (1932), "A correlation of ring-shaped chromosomes with variegation in Zea Mays", Proc. Natl. Acad. Sci. (USA) , 18, 677-681.
Mulligan et al, (1980) , "Expression of a bacterial gene in mammalian cells", Science, 209, 1422-1428.
Mulligan et al, (1981) , "Selection for animal cells that express the Escherichia coli gene coding for xanthine- guanine phosphoribosyltransferase" , Proc. Natl. Acad. Sci. (USA) , 78, 2072-2076.
Murray et al, (1993), "The Cell Cycle"; Oxford Univ. Press.
Nurse, P., (1980), "Universal control mechanism regulating the onset of M phase", Nature, 344, 503-508.
Oakey et al, (1990) , "Y chromosome haplotyping suggests that most European and Asian men are descended from one or two males", Genomics, 7, 325-330.
Page et al, (1984) , "Occurrence of a transposition from the X-chromosome long arm to the Y chromosome short arm during human evolution", Nature 311, 119-123.
Page et al, "The sex determining region of the human Y chromosome encodes a finger protein", Cell, 51, 1091-
1104 .
Rasheed et al, (1974) , "Characterization of a newly derived human sarcoma line (HT1080) " , Cancer, 33, 1027- 1033.
Rhoades, M.M., (1938) , "On the origin of secondary trisome through the doubling of a half-chromosome fragment", Genetics, 23, 163-164.
Rouyer et al, (1986) , "A gradient of sex linkage in the pseudoautosomal region of the human sex chromosomes", Nature 319, 291-295.
Smith G.P., (1976) , "Evolution of repeated DNA sequences by unequal cross-over", Science, 191, 528-535.
Southern, E.M., (1975), "Long range periodicities in mouse satellite DNA", J. Mol. Biol., 94, 51-69.
Stotz et al, (1990) , "The ADE2 gene from Saccharomyces cerevisiae, sequence and new vectors", Gene, 95, 91-98.
Surosky et al, (1985) , "Construction of telocentric chromosomes in Saccharomyces cerevisiae", Proc. Natl. Acad. Sci. (USA) ., 82, 2106-2110.
Tyler-Smith, C, (1987), "Structure of repeated sequences in the centromeric region of the human Y chromosome", Differentiation (Suppl.), 101, 93-100.
Tyler-Smith et al, (1987) , "Structure of the major block of alphoid satellite DNA on the human Y chromosome", J. Mol. Biol., 195, 457-470.
Tyler-Smith et al, (1988) , "Structure of a hypervariable tandemly repeated DNA sequence on the short arm of the
human Y chromosome", J. Mol. Biol., 203, 837-848.
Tyler-Smith et al, (1993) , "Localization of DNA sequences required for human centromere function through an analysis of rearranged Y chromosomes", Nature Genet., 5, 368-375.
Claims
1. A vector comprising a chromosome fragment which fragment comprises sequences which have centromeric activity, is capable of replication and segregation during cell cycle, and is of such a size that it can be resolved using gel electrophoresis.
2. A vector according to claim 1 which is derived from the human Y chromosome.
3. A vector according to claim 2 comprising a linear derivative of the human Y chromosome which includes at least some alphoid DNA.
4. A vector according to claim 2 or claim 3 which is derived solely from the short arm of the human Y chromosome.
5. A vector according to claims 2 or claim 3 which is derived solely from the long arm of the human Y chromosome.
6. A vector according to any one of the preceding claims which is less than 6Mb in size.
7. A vector according to claim 6 which is less than 3.5 megabase in size.
8. A process for obtaining a vector according to any one of the preceding claims which process comprises dissecting a chromosome in such a manner that a fragment retaining centromere function is retained.
9 A process according to claim 8 which utilises telomere directed truncation wherein cloned telomeric DNA is used to effect a break in the chromosome.
10. A process according to claim 9 wherein the truncation is repeated in order to obtain a fragment of the desired size.
11. A process according to claim 10 wherein the truncation process is repeated and after each truncation step, the ability of the fragments obtained to replicate and segregate during cell cycle is confirmed by a mitosis experiments and only those which are mitotically stable to a reasonable extent selected for further truncation.
10. A process according to claim 9 wherein the said mitosis experiments are carried out using in si tu hybridisation to chromosomes in whole cells.
11. A process for obtaining a vector which process comprises dissecting a chromosome using a pair of vectors each containing telomeric DNA, a marker gene, and chromosomal DNA from the centromeric region in opposite orientations in the two vectors, introducing the vectors into cells containing the chromosome, selecting cells which have stably integrated vector, and isolating a clone containing a chromosome derivative which has lost one arm of the chromosome but retained the other arm truncated by telomere-directed breakage within the centromeric array, such clone segregating accurately at mitosis and being retained by cells proliferating in the absence of selection.
12. A process according to claim 11 wherein the selected clone is subjected to a further round of telomere- directed breakage to obtain a mini-chromosome fragment which is maintained stably by cells proliferating in culture .
13. A process according to claim 11 or claim 12 which comprises the steps of carrying out a first telomere- directed truncation of the human Y chromosome, isolating stably segregating a fragment which contains only short arm and alphoid DNA, carrying out a second telomere- directed truncation of the isolated fragment, and isolating a shorter stably segregating fragment.
14. A vector according to any one of claims 1- 7 which further comprises a gene encoding a desired polypeptide or protein.
15. A cell transformed using a vector according to claim 14.
16. A vector according to claim 14 for use in gene therapy.
17. A pharmaceutical composition comprising a vector according to claim 16 in combination with a pharmaceutically acceptable carrier or diluent.
18. A vector according to claim 14 for use in animal transgenesis.
19. A method for treating a host by administering a gene which expresses a polypeptide or protein of therapeutic use to said host, which method comprises forming a vector as described above including a desired gene and incorporating the said vector into the host cells.
20. A vector obtainable by a process according to claim 11.
21. A vector comprising Δl obtainable from cell line having the accession number ECACC 95052342.
22. A vector comprising Δ7 obtainable from cell line having the accession number ECACC 95052343.
23. A vector comprising Δ128 obtainable from cell line having the accession number ECACC 95052344.
24. A vector comprising Δ196 obtainable from cell line having the accession number ECACC 95052345
25. A cell line selected from any one of those having the accession numbers ECACC95052342, ECACC 95052343, ECACC 95052344 and ECACC 95052345.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU25343/95A AU2534395A (en) | 1994-05-25 | 1995-05-25 | Novel chromosome fragment and its use as a vector |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9410446.0 | 1994-05-25 | ||
GB9410446A GB9410446D0 (en) | 1994-05-25 | 1994-05-25 | Novel chromosome fragment |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1995032297A1 true WO1995032297A1 (en) | 1995-11-30 |
WO1995032297B1 WO1995032297B1 (en) | 1996-01-18 |
Family
ID=10755674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1995/001195 WO1995032297A1 (en) | 1994-05-25 | 1995-05-25 | Novel chromosome fragment and its use as a vector |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU2534395A (en) |
GB (1) | GB9410446D0 (en) |
WO (1) | WO1995032297A1 (en) |
ZA (1) | ZA954300B (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996040965A1 (en) * | 1995-06-07 | 1996-12-19 | Case Western Reserve University | Synthetic mammalian chromosome and methods for construction |
WO1997040183A2 (en) * | 1996-04-10 | 1997-10-30 | The Biological Research Center Of The Hungarian Academy Of Sciences | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
US5712134A (en) * | 1990-05-09 | 1998-01-27 | The Biological Research Center Of The Hungarian Academy Of Sciences | Method of producing a cell carrying an excess of mammalian centromeres |
WO1998008964A1 (en) * | 1996-08-26 | 1998-03-05 | Tsuneko Okazaki | Mammalian artificial chromosomes |
US5869294A (en) * | 1995-06-07 | 1999-02-09 | Case Western Reserve University | Method for stably cloning large repeating DNA sequences |
US6077697A (en) * | 1996-04-10 | 2000-06-20 | Chromos Molecular Systems, Inc. | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
WO2002010375A1 (en) * | 2000-07-17 | 2002-02-07 | Jiahui Xia | Human source gene leading sequence, gene vector and gene expression strategy |
US6632976B1 (en) | 1995-08-29 | 2003-10-14 | Kirin Beer Kabushiki Kaisha | Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene |
US7371568B1 (en) | 1998-08-21 | 2008-05-13 | Kirin Pharma Kabushiki Kaisha | Method for modifying chromosomes |
US7402729B2 (en) | 2001-05-11 | 2008-07-22 | Kirin Pharma Kabushiki Kaisha | Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission |
US8835712B2 (en) | 2000-11-30 | 2014-09-16 | Medarex, L.L.C. | Transgenic trasnchromosomal rodents for making human antibodies |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989009219A1 (en) * | 1988-03-24 | 1989-10-05 | The General Hospital Corporation | Artificial chromosome vector |
US4889806A (en) * | 1987-04-15 | 1989-12-26 | Washington University | Large DNA cloning system based on yeast artificial chromosomes |
WO1995003400A1 (en) * | 1993-07-23 | 1995-02-02 | Johns Hopkins University School Of Medicine | Recombinationally targeted cloning in yeast artificial chromosomes |
-
1994
- 1994-05-25 GB GB9410446A patent/GB9410446D0/en active Pending
-
1995
- 1995-05-25 AU AU25343/95A patent/AU2534395A/en not_active Abandoned
- 1995-05-25 WO PCT/GB1995/001195 patent/WO1995032297A1/en active Application Filing
- 1995-05-25 ZA ZA954300A patent/ZA954300B/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4889806A (en) * | 1987-04-15 | 1989-12-26 | Washington University | Large DNA cloning system based on yeast artificial chromosomes |
WO1989009219A1 (en) * | 1988-03-24 | 1989-10-05 | The General Hospital Corporation | Artificial chromosome vector |
WO1995003400A1 (en) * | 1993-07-23 | 1995-02-02 | Johns Hopkins University School Of Medicine | Recombinationally targeted cloning in yeast artificial chromosomes |
Non-Patent Citations (6)
Title |
---|
BARNETT,M.A. ET AL., NUCLEIC ACIDS RESEARCH, vol. 21, pages 27 - 36 * |
BROWN,W.R.A., CURR. OPIN. GENET. DEV., vol. 2, pages 479 - 486 * |
PAVAN, W.J. ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 87, pages 1300 - 1304 * |
SUROSKY, R.T. AND TYE, B.-K., PROC. NATL. ACAD. SCI. U.S.A., vol. 82, pages 2106 - 2110 * |
TAYLOR, S.S. ET AL., HUM. MOL. GENET., vol. 3, no. 8, pages 1383 - 1386 * |
TYLER-SMITH, C. ET AL., NATURE GENET., vol. 5, pages 368 - 375 * |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5712134A (en) * | 1990-05-09 | 1998-01-27 | The Biological Research Center Of The Hungarian Academy Of Sciences | Method of producing a cell carrying an excess of mammalian centromeres |
US5891691A (en) * | 1990-05-09 | 1999-04-06 | The Biological Research Center Of The Hungarian Academy Of Sciences | Method of producing a cell carrying an excess of mammalian centromeres and the cell line carrying an excess of mammalian centromeres |
WO1996040965A1 (en) * | 1995-06-07 | 1996-12-19 | Case Western Reserve University | Synthetic mammalian chromosome and methods for construction |
US5869294A (en) * | 1995-06-07 | 1999-02-09 | Case Western Reserve University | Method for stably cloning large repeating DNA sequences |
US6348353B1 (en) | 1995-06-07 | 2002-02-19 | Case Western Reserve University | Artificial mammalian chromosome |
US8110671B2 (en) | 1995-08-29 | 2012-02-07 | Kyowa Hakko Kirin Co., Ltd. | Isolated human chromosome 14 fragment encoding immunoglobulin genes |
US6632976B1 (en) | 1995-08-29 | 2003-10-14 | Kirin Beer Kabushiki Kaisha | Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene |
WO1997040183A2 (en) * | 1996-04-10 | 1997-10-30 | The Biological Research Center Of The Hungarian Academy Of Sciences | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
WO1997040183A3 (en) * | 1996-04-10 | 1998-02-05 | Biolog Research Center Of The | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
US6025155A (en) * | 1996-04-10 | 2000-02-15 | Chromos Molecular Systems, Inc. | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
US6077697A (en) * | 1996-04-10 | 2000-06-20 | Chromos Molecular Systems, Inc. | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
EP2314708A1 (en) * | 1996-04-10 | 2011-04-27 | Chromos Molecular Systems, Inc. | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
US6569643B2 (en) | 1996-08-26 | 2003-05-27 | Tsuneko Okazaki | Mammalian artificial chromosomes |
WO1998008964A1 (en) * | 1996-08-26 | 1998-03-05 | Tsuneko Okazaki | Mammalian artificial chromosomes |
EP2060633A1 (en) * | 1996-08-26 | 2009-05-20 | Chromo Research, Inc. | Mammalian artificial chromosomes |
US6297029B1 (en) | 1996-08-26 | 2001-10-02 | Tsuneko Okazaki | Mammalian artificial chromosomes |
US7371568B1 (en) | 1998-08-21 | 2008-05-13 | Kirin Pharma Kabushiki Kaisha | Method for modifying chromosomes |
US8124406B2 (en) | 1998-08-21 | 2012-02-28 | Kyowa Hakko Kirin Co., Ltd | Method for modifying chromosomes |
US7868223B2 (en) | 1998-08-21 | 2011-01-11 | Kyowa Hakko Kirin Co., Ltd. | Method for modifying chromosomes |
WO2002010375A1 (en) * | 2000-07-17 | 2002-02-07 | Jiahui Xia | Human source gene leading sequence, gene vector and gene expression strategy |
US8835712B2 (en) | 2000-11-30 | 2014-09-16 | Medarex, L.L.C. | Transgenic trasnchromosomal rodents for making human antibodies |
US9426970B2 (en) | 2000-11-30 | 2016-08-30 | E. R. Squibb & Sons, L.L.C. | Transgenic transchromosomal rodents for making human antibodies |
US10076103B2 (en) | 2000-11-30 | 2018-09-18 | Kyowa Hakko Kirin Co., Ltd. | Transgenic transchromosomal rodents for making human antibodies |
US7476536B2 (en) | 2001-05-11 | 2009-01-13 | Kirin Pharma Kabushiki Kaisha | Artificial human chromosome containing human antibody a light chain gene |
US7402729B2 (en) | 2001-05-11 | 2008-07-22 | Kirin Pharma Kabushiki Kaisha | Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission |
US9499838B2 (en) | 2001-05-11 | 2016-11-22 | Kyowa Hakko Kirin Co., Ltd. | Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission |
US10448622B2 (en) | 2001-05-11 | 2019-10-22 | E. R. Squibb & Sons, L.L.C. | Human artificial chromosome containing human antibody lambda light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission |
Also Published As
Publication number | Publication date |
---|---|
GB9410446D0 (en) | 1994-07-13 |
ZA954300B (en) | 1996-01-24 |
AU2534395A (en) | 1995-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brown et al. | Dissecting the centromere of the human Y chromosome with cloned telomeric DNA | |
JP2721666B2 (en) | Site-specific recombination of DNA in yeast | |
US5776745A (en) | Recombinationally targeted cloning in yeast artificial chromosomes | |
Pavan et al. | Modification and transfer into an embryonal carcinoma cell line of a 360-kilobase human-derived yeast artificial chromosome | |
AU764916B2 (en) | Transformation-associated recombination cloning | |
US20070117202A1 (en) | Novel nucleic acid molecule | |
AU689015B2 (en) | Library screening method | |
Tambini et al. | TheXRCC2DNA Repair Gene: Identification of a Positional Candidate | |
WO1995032297A1 (en) | Novel chromosome fragment and its use as a vector | |
Jeannotte et al. | Low level of Hox1. 3 gene expression does not preclude the use of promoterless vectors to generate a targeted gene disruption | |
Taylor et al. | Analysis of extrachromosomal structures containing human centromeric alphoid satellite DNA sequences in mouse cells | |
Hugerat et al. | A versatile method for efficient YAC transfer between any two strains | |
KR20020057943A (en) | Trap Vector and Gene Trapping Method by Using the Same | |
Lien et al. | Regulation of the myeloid-cell-expressed human gp91-phox gene as studied by transfer of yeast artificial chromosome clones into embryonic stem cells: suppression of a variegated cellular pattern of expression requires a full complement of distant cis elements | |
Davis et al. | Correlation of the physical and genetic maps of the centromeric region of the right arm of linkage group III of Neurospora crassa. | |
Lycett et al. | Stable transformation of mosquito cell lines using a hsp70:: neo fusion gene | |
JP2001506498A (en) | Consensus sequences for human and mammalian DNA origin of replication | |
Bermingham Jr et al. | Chromosomal localization of mouse and human genes encoding the splicing factors ASF/SF2 (SFRS1) and SC-35 (SFRS2) | |
Reeves et al. | [49] Yeast artificial chromosome modification and manipulation | |
WO1993001292A1 (en) | Interstitial deletion in chromosomal dna | |
EP1661992B1 (en) | Method of screening for homologous recombination events | |
Ramsay et al. | Yeast Artificial-Chromosome (YAC) Cloning Systems | |
US6342354B1 (en) | Method to map and isolate regions of chromosomes that interact or associate functionally within or between chromosomes in vivo | |
Merrell et al. | Genetic analyses of tattered, an X-linked dominant, developmental mouse mutation | |
Russo et al. | Insertional mutagenesis and mouse development |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |